SCHEMBL4320074

SCHEMBL4320074

CC(=O)Nc1ccc(C(Cl)=NO)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
TP53 P04637 2/20 0.56
HIF1A Q16665 1/20 0.56
SMN1; SMN2 Q16637 5/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
HTT P42858 2/20 0.53
KMT2A Q03164 6/20 0.52
MEN1 O00255 4/20 0.52
MAPT P10636 4/20 0.52
TDP1 Q9NUW8 1/20 0.52
CA12 O43570 1/20 0.52
BRD4 O60885 1/20 0.52
NR1I2 O75469 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
MB P02144 1/20 0.52
CYP1A1 P04798 1/20 0.52
CA3 P07451 1/20 0.52
CYP3A4 P08684 1/20 0.52
RARG P13631 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4320072 1.00 ALDH1A1 (0.56) ALDH1A1TP53HIF1ASMN1; SMN2L3MBTL1
SCHEMBL203798 0.82 ALDH1A1 (0.54) ALDH1A1TP53HIF1ASMN1; SMN2L3MBTL1
SCHEMBL203797 0.82 ALDH1A1 (0.54) ALDH1A1TP53HIF1ASMN1; SMN2L3MBTL1
SCHEMBL64499 0.80 ALDH1A1 (0.63) ALDH1A1TP53HIF1ASMN1; SMN2L3MBTL1
SCHEMBL202111 0.78 ALDH1A1 (0.53) ALDH1A1TP53HIF1ASMN1; SMN2L3MBTL1
SCHEMBL202112 0.78 ALDH1A1 (0.53) ALDH1A1TP53HIF1ASMN1; SMN2L3MBTL1
SCHEMBL14503399 0.78 CYP17A1 (0.51) MAPTCA12CA1CA9
SCHEMBL10632992 0.78 SMN1; SMN2 (0.53) ALDH1A1TP53HIF1ASMN1; SMN2L3MBTL1
SCHEMBL10429142 0.78 SMN1; SMN2 (0.53) ALDH1A1TP53HIF1ASMN1; SMN2L3MBTL1
SCHEMBL10886486 0.78 HDAC1 (0.57) ALDH1A1TP53HIF1ASMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009137380-A1 3-HYDRAZONE PIPERAZINYL RIFAMYCIN DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS JANSSEN PHARMACEUTICA NV (BE) 2009-11-12 WO disclosed
US-20090275594-A1 3-HYDRAZONE PIPERAZINYL RIFAMYCIN DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS JANSSEN PHARMACEUTICA NV (BE) 2009-11-05 US disclosed
US-5378702-A Thiadizinones MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1995-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275594-A1 3-HYDRAZONE PIPERAZINYL RIFAMYCIN DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS RIF1, ABCC1, HDAC6 ALDH1A1 1070/4885TP53 2684/4885HIF1A 970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.